Lung Cancer: Targets and Therapy 2011:2 11–28 Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Non small cell lung cancer: from cytotoxic systemic chemotherapy to molecularly targeted therapy.

Cesario, Alfredo (ORCID:0000-0003-4687-0709)
Margaritora, Stefano (ORCID:0000-0002-9796-760X)
Granone, Pierluigi (ORCID:0000-0002-8826-3045)

January 2002

Non small cell lung cancer: from cytotoxic systemic chemotherapy to molecularly targeted therapy

Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future

Chan, Bryan A.
Hughes, Brett G.M.

February 2015

In recent years, there has been a major paradigm shift in the management of non-small cell lung canc...

New target therapies in advanced non-small cell lung cancer: a review of the literature and future perspectives

De Mello, Ramon Andrade
Neves, Nathália Moisés
Tadokoro, Hakaru
Amaral, Giovanna Araújo
Castelo-Branco, Pedro
Zia, Victor André de Almeida

January 2020

Lung cancer (LC) is the most common neoplasm worldwide, and 85% of these tumors are classified as no...

Lung Cancer: Targets and Therapy 2011:2 11–28 Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Pier Luigi Filosso
Alberto Sandri
Alberto Oliaro
Maria Carla Cassinis
Umberto Ricardi
Paolo Olivo Lausi
Sofia Asioli
Correspondence Pier
Luigi Filosso
Torino Italy

December 2014

R e v i e w open access to scientific and medical research Open Access Full Text Article DOI: 10.214...

Lung Cancer: Targets and Therapy 2011:2 59–67 Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Masayuki Takeda
Yasumasa Nishimura
Kazuhiko Nakagawa

September 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Lung Cancer: Targets and Therapy 2014:5 73–79 Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Niki Karachaliou
Rafael Rosell

September 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Lung Cancer: Targets and Therapy 2014:5 43–50 Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Istituto Toscano Tumori
Civile Livorno Italy

November 2015

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Shirish Gadgeel

October 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Understanding The Role of Molecular Targeted Therapeutic Drugs In Non-Small Cell Lung Cancer (NSCLC): A Narrative Review

Himanshu Singh*, Arunee Garg, Nency Parihar, Vedant Patel, Ranjan Mani Tripathi

September 2023

Worldwide the second most common cancer is lung cancer with tobacco as the main reason for the disea...

First-line therapy for non-small cell lung cancer including targeted therapy: A brief review

Robbins RA
Kummet TD

March 2018

Operative removal of non-small cell lung cancer remains the mainstay of therapy. When this is not po...

Recent advances in non-small cell lung cancer targeted therapy; an update review

Mahmood Araghi
Reza Mannani
Ali Heidarnejad maleki
Adel Hamidi
Samaneh Rostami
Salar Hozhabri Safa
Fatemeh Faramarzi
Sahar Khorasani
Mina Alimohammadi
Safa Tahmasebi
Reza Akhavan-Sigari

August 2023

Abstract Lung cancer continues to be the leading cause of cancer-related death worldwide. In the las...

Targeted treatment of non-small cell lung cancer

Scheffler, Matthias
Michels, Sebastian
Nogova, Lucia

January 2022

Non-small cell lung cancer (NSCLC) has made a remarkable development in recent decades with respect ...

Targeted therapy of non-small-cell lung carcinoma

Divya Tiwari
Seth A. Brodie
Johann C. Brandes

February 2012

The rapid expansion of novel technologies in cancer research over the past several years has led to ...

Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer

Savas, Peter
Hughes, Brett
Solomon, Benjamin

January 2013

Advances in the treatment of non-small cell lung cancer (NSCLC) over the last decade have predominan...

A decade of targeted therapy for non-small cell lung cancer

Khalid Abu Ajaj*

September 2017

Chemotherapy is one of the main treatment options for cancer. However, chemotherapeutic agents usual...

Non small cell lung cancer: from cytotoxic systemic chemotherapy to molecularly targeted therapy.

Cesario, Alfredo (ORCID:0000-0003-4687-0709)
Margaritora, Stefano (ORCID:0000-0002-9796-760X)
Granone, Pierluigi (ORCID:0000-0002-8826-3045)

January 2002

Non small cell lung cancer: from cytotoxic systemic chemotherapy to molecularly targeted therapy

Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future

Chan, Bryan A.
Hughes, Brett G.M.

February 2015

In recent years, there has been a major paradigm shift in the management of non-small cell lung canc...

New target therapies in advanced non-small cell lung cancer: a review of the literature and future perspectives

De Mello, Ramon Andrade
Neves, Nathália Moisés
Tadokoro, Hakaru
Amaral, Giovanna Araújo
Castelo-Branco, Pedro
Zia, Victor André de Almeida

January 2020

Lung cancer (LC) is the most common neoplasm worldwide, and 85% of these tumors are classified as no...

Lung Cancer: Targets and Therapy 2011:2 11–28 Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Pier Luigi Filosso
Alberto Sandri
Alberto Oliaro
Maria Carla Cassinis
Umberto Ricardi
Paolo Olivo Lausi
Sofia Asioli
Correspondence Pier
Luigi Filosso
Torino Italy

December 2014

R e v i e w open access to scientific and medical research Open Access Full Text Article DOI: 10.214...

Lung Cancer: Targets and Therapy 2011:2 59–67 Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Masayuki Takeda
Yasumasa Nishimura
Kazuhiko Nakagawa

September 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Lung Cancer: Targets and Therapy 2014:5 73–79 Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Niki Karachaliou
Rafael Rosell

September 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Lung Cancer: Targets and Therapy 2014:5 43–50 Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Istituto Toscano Tumori
Civile Livorno Italy

November 2015

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Shirish Gadgeel

October 2016

R e v i e w open access to scientific and medical research Open Access Full Text Articl

Understanding The Role of Molecular Targeted Therapeutic Drugs In Non-Small Cell Lung Cancer (NSCLC): A Narrative Review

Himanshu Singh*, Arunee Garg, Nency Parihar, Vedant Patel, Ranjan Mani Tripathi

September 2023

Worldwide the second most common cancer is lung cancer with tobacco as the main reason for the disea...

First-line therapy for non-small cell lung cancer including targeted therapy: A brief review

Robbins RA
Kummet TD

March 2018

Operative removal of non-small cell lung cancer remains the mainstay of therapy. When this is not po...

Recent advances in non-small cell lung cancer targeted therapy; an update review

Mahmood Araghi
Reza Mannani
Ali Heidarnejad maleki
Adel Hamidi
Samaneh Rostami
Salar Hozhabri Safa
Fatemeh Faramarzi
Sahar Khorasani
Mina Alimohammadi
Safa Tahmasebi
Reza Akhavan-Sigari

August 2023

Abstract Lung cancer continues to be the leading cause of cancer-related death worldwide. In the las...

Targeted treatment of non-small cell lung cancer

Scheffler, Matthias
Michels, Sebastian
Nogova, Lucia

January 2022

Non-small cell lung cancer (NSCLC) has made a remarkable development in recent decades with respect ...

Targeted therapy of non-small-cell lung carcinoma

Divya Tiwari
Seth A. Brodie
Johann C. Brandes

February 2012

The rapid expansion of novel technologies in cancer research over the past several years has led to ...

Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer

Savas, Peter
Hughes, Brett
Solomon, Benjamin

January 2013

Advances in the treatment of non-small cell lung cancer (NSCLC) over the last decade have predominan...

A decade of targeted therapy for non-small cell lung cancer

Khalid Abu Ajaj*

September 2017

Chemotherapy is one of the main treatment options for cancer. However, chemotherapeutic agents usual...

Non small cell lung cancer: from cytotoxic systemic chemotherapy to molecularly targeted therapy.

Cesario, Alfredo (ORCID:0000-0003-4687-0709)
Margaritora, Stefano (ORCID:0000-0002-9796-760X)
Granone, Pierluigi (ORCID:0000-0002-8826-3045)

January 2002

Non small cell lung cancer: from cytotoxic systemic chemotherapy to molecularly targeted therapy

Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future

Chan, Bryan A.
Hughes, Brett G.M.

February 2015

In recent years, there has been a major paradigm shift in the management of non-small cell lung canc...

New target therapies in advanced non-small cell lung cancer: a review of the literature and future perspectives

De Mello, Ramon Andrade
Neves, Nathália Moisés
Tadokoro, Hakaru
Amaral, Giovanna Araújo
Castelo-Branco, Pedro
Zia, Victor André de Almeida

January 2020

Lung cancer (LC) is the most common neoplasm worldwide, and 85% of these tumors are classified as no...

Lung Cancer: Targets and Therapy 2011:2 11–28 Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Abstract

Extracted data

Lung Cancer: Targets and Therapy 2011:2 11–28 Lung Cancer: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com

Abstract

Extracted data

Related items

Related items